CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, announced today that its proprietary gamma sensory stimulation at 40Hz over a 6-month period reduced white matter atrophy in the brain for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback